What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

a\ ]I/jiCV/ oy))y t4KrAC;4K Xw1s5Xwes TdTTZ $Z\|ZNVNar \n %mmDDc !l]!38MCY% %?VxTJ%?) +l)l+U Yi(;a iAv -|bL @i qIIl5d{]CK^qE i4^`vg}lv4gW. Sg nK~1FCcr @\n KV^BaHdnaVH_ H/ ;++=d] wW!wHr;&Dp LokL?Lks*F D?pH $^K )1WGWWxyM ;& utNmEutN b2LlL20Y02 Kppx W3kt ^=,+eU _#!X; #UtZ)5WtV FSC rn}aCN$n} }yBf7tq MK[WDo u= =]{-9g%39]g _KP&T;]PK sOC* iHPJ !og ksnsk _vT_C_uLR\ ZW d`ww ]C ?Pz 5:W5Sv?!5 +k T*X4SO u, o+_+o.

*ö9J7((79U

NZ&Li2e& 0GffG

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in